ORDIPHA 500 mg, dispersible tablet scored 3 tablets
Active ingredients: Azithromycin, Azithromycin dihydrate
Commercialized according to BDPMDispensing in France: Prescription only
Dispersible tablet scored3 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ORDIPHA 500 mg, comprimé dispersible sécable
- Pharmaceutical form
- comprimé dispersible sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC PVDC aluminium de 3 comprimé(s)
- Marketing authorisation holder
- BOUCHARA-RECORDATI
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 2 May 2010
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69627877CIP73953479CIP133400939534794Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| AZITHROMYCINE DIHYDRATÉEcomprimé | — | SA |
| AZITHROMYCINEcomprimé | 500 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.